Biotech Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Brigham & Women's Hospital, Boston

Data support routine clopidogrel pretreatment in patients undergoing PCI

According to investigators in the United States, "The benefit of clopidogrel pretreatment before percutaneous coronary intervention (PCI) remains debated and its use has not been universally adopted. [Our objective was] to determine if clopidogrel pretreatment before PCI in patients with recent ST-segment elevation myocardial infarction (STEMI) is superior to clopidogrel treatment initiated at the time of PCI in preventing major adverse cardiovascular events."

...

• View Other Issues of Biotech Law Weekly
  
• View Other NewsRx Publications